Member Info for euclid55

I still see no BoD's have bought any shares since listing, especially DSwick, very poor imo

page 106

2. Syminex facility
On 10 August 2018, the Subsidiary, DevClever Limited, entered into a secured facility agreement with Syminex for a convertible loan facility of £210,000, included in Cash and cash equivalents. Included within Loans and borrowings is the principal amount due of £210,000, plus interest payable of £10,000.

Syminex has elected to convert the loan facility, plus interest of £10,000, to Ordinary shares on the date of the IPO.
For details of this material contract, please see Paragraph 14 Syminex Facility of Section 12 Material Contracts in Part VII Additional information of the prospectus.

An adjustment has been made to reflect the proceeds of a placing of 59,000,000 Ordinary Shares of the Company at an issue price of £0.01 per Ordinary Share, net of an adjustment to reflect the payment in cash of admission costs estimated at approximately £217,900.

On the date of the Placing, the £210,000 Syminex facility and £10,000 interest will be converted to 22,000,000 Ordinary Shares at an issue price of £0.01 per Ordinary Share.

Https://devcleverholdingsplc.com/wp-content/uploads/2019/01/prospectus.pdf

Potter, we just have to wait, these type of business do take time to unfold

the impatient can sell the patient can wait & bide their time if they can.

too many protocols to go through in this type of product / business

Competition from existing and new companies

The Group operates in a competitive market in which several players have a more substantial product portfolio
and market presence. The Group has an abundance of competitors of a similar size to its own, who compete with
the Group in one or more markets in which the Group operates. Some of the Group’s competitors are larger
entities. For example, Eagle Eye Solutions Group plc is active in development of loyalty platforms, whilst Catalina
and Valassis currently dominate the market for paper and/or plastic solutions in the UK. These competitors have
greater financial and technological resources, larger sales and marketing organisations and greater name
recognition than the Group, and may therefore be better able to obtain sales through their pricing structure, heavy
marketing or reputation.

The Group is unable to assure investors that future competitors will not emerge, develop and/or introduce new
products which will compete with those of the Group on grounds of superior technology, lower price or otherwise.
It is uncertain how long a lead time the Group will have with its innovations and how rapidly competition from
other suppliers or alternative technologies may develop. Technological change in the sector within which the
Group operates may render the Group’s products less competitive or even obsolete.

https://devcleverholdingsplc.com/wp-content/uploads/2019/01/prospectus.pdf

The Group’s Intellectual property

Whilst the majority of the Group’s products and processes are proprietary, the Group has at this time limited
protection of its intellectual property. The commercial success of the Group depends in part on its ability to
protect and exploit its intellectual property and to preserve the confidentiality of its intellectual property.

The Group may not be able to protect and preserve its intellectual property rights or to exclude competitors with
similar products and/or processes

https://devcleverholdingsplc.com/wp-content/uploads/2019/01/prospectus.pdf

The Group has limited protection of its intellectual property. The Group
may be unable to protect its intellectual property and to exclude
competitors with similar products and/or processes

above from pg 16 of prospectus

https://devcleverholdingsplc.com/wp-content/uploads/2019/01/prospectus.pdf

Does anyone have the last Cenkos broker note... think they gave it a 8p TP....with detailed info in the report

can't recall, but there are a few companies in this business listed in Europe / Gilbrater & much larger players - don't think that there are just 2 or 3 players in Europe / Asia - there are plenty more than that if you google research

that wasn't SL Investment Management Ltd that was listed - the listed co was called:
Alternative Asset Opportunities PCC Limited - epic code TLI

It was a managed fund run by AGI: but the Fund manager was SL Investments Ltd - recall finding this n my research when SL managed funds for Allianz Global then it was sold off to Vida Longevity L.P and Life Equity LLC

"THAT the Company's books and records be held by the Manager of the Company, Allianz Global Investors GmbH"

https://www.investegate.co.uk/altern-asset-opps-ld--tli-/rns/shareholder-update/201612081238463480R/

Investment in Life Settlements

SL Investment Management (SL) is considered to be one of the largest
and most expert ‘full service’ secondary life policy specialists in
Europe.

http://aceso.in/Knowledge_Center/Life_settlement_leaflet__June_2017.pdf

Fish cake, you are talking very very conservative - go back to the ramping training room again

I see the market cap at £100 B, not a pissy £200m - wake up son - if this was in Nasdaq it will be capped for a few 100 Billions - IBM or even Facebook may buy them out for $150b

How many actual schools / colleges' have signed up for this product then?

what is their projected future income / net profit from this product in YE 2019 / 2020

they have the potential to infiltrate every school, college, university, apprentiship provider in the UK. This is based on there efficacy of their product and also the fact they fulfil the governments latest mandatory requirements to schools.

The 1m buy hasn't budged the price up at all

Think your market cap estimations are a bit pie in the sky values - clever ramping on your behalf

Tried Launch your career website, don't think it's that unique at all

wonder if they will sell some of their 9m shares on or after he 21 March 2019

issued to Hargreave Hale Limited ("Hargreave Hale") on 24th October 2018 ("CLN Repayment") and the proposed subscription by Hargreave Hale for 10,444,444 new ordinary shares of no par value in the Company ("New Ordinary Shares") for a price of 9 pence per share

Is the below the connection to get their Hybrid product approved by the PRA - so any insurers can buy into it and add it it to their balance sheet - to benefit from holding fewer reserves v's higher returns from the Hybrid returns in Life settlements.The London Stock Exchange is now ready to list insurance-linked securities (ILS) on its International Securities Market after putting in place the rules necessary to allow for listing of catastrophe bonds and other ILS securities.http://www.artemis.bm/news/london-stock-exchange-ready-to-list-insurance-linked-securities/

Dave Ellerby
?


@ellerby_dave
6h
6 hours ago


Dave Ellerby Retweeted Dave Ellerby
#AlGW

Wow,listened again. This guy is on the ball.
He brings Core Actuarial Experience into Alpha with roles to:
Understand, design&price Insurance policies
To Minimise premiums & Maximise returns for Pol Holders
To work 4 the Policyholder
If u are excited by the potential BUY IN

https://twitter.com/ellerby_dave/status/1103909214651527168

new NeD well connected, appeared in this conference along woth Alec Taylor (director at SL Invst Mngt Ltd - our JV partner - plus Gareth Mee (Executive director at EY)

International Life Settlement Conference 2016

3:15 – 4:15 p.m. “Latest developments in the UK secondary annuities market”

Panel: - Alec Taylor (Lead UK TEP & Marketing
SL Investment Management, ELSA Chair)
- Jason Sutherland (Director of Capital Markets & Legal Counsel at DRB Capital)
- Gareth Mee (Executive Director, EY)
________________________________________

Mr. Sutherland has over 17 years of
experience as an attorney and senior
executive in the specialty finance
area. Mr. Sutherland currently serves
as the Director of Capital Markets &
Legal Counsel at DRB Capital.

He is also the founder of Citadel
Financial, Ltd (“Citadel”). Prior to
Citadel, Mr. Sutherland served as the
Vice President of Legal Affairs for
Peachtree Settlement Funding where
he concentrated on the creation of
financing facilities, term securitizations and managed litigation efforts
on a nationwide basis. On behalf of
Peach Holdings, LLC he also founded
and served as the Managing Director-Legal & Operations for Peachtree
Asset Management, Ltd (an FCA regulated firm) and managed its fund
related activities. Prior to that, he was
employed at the law firm of Powell,
Goldstein, Fraser & Murphy as an
Associate Attorney.

Mr. Sutherland received his B.A. from
The University of Georgia – Athens
and his J.D. from New England
Law-Boston. He is a board member
of the National Association of Settlement Purchasers and the Chairman of
the Legal and Legislative Committee

Http://bvzl.de/wp-content/uploads/2017/06/16092016_BVZL_ELSA_Conference_2016_Agenda_final__1.pdf

The London Stock Exchange is now ready to list insurance-linked securities (ILS) on its International Securities Market after putting in place the rules necessary to allow for listing of catastrophe bonds and other ILS securities.

Http://www.artemis.bm/news/london-stock-exchange-ready-to-list-insurance-linked-securities/

1.71p was a 900,000 sell at that price!

Ok thanks for clarifying.. waiting for TR1 confirm via co release